Alzheimer’s Disease: The Challenge of the Second Century

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864

A default mode of brain function

Raichle, M. E., MacLeod, A. M., Snyder, A. Z., Powers, W. J., Gusnard, D. A., & Shulman, G. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.676 · Cited by 12,190

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359

The Clinical Dementia Rating (CDR): Current version and scoring rules

Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429

Finding the missing heritability of complex diseases

Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806

Netrin-1 receptor UNC5C cleavage by active δ-secretase enhances neurodegeneration, promoting Alzheimer’s disease pathologies

Chen, G., Kang, S. S., Wang, Z., Ahn, E. H., Xia, Y., Liu, X., Sandoval, I. M., Manfredsson, F. P., Zhang, Z., & Ye, K. (2021) · Science Advances · doi:10.1126/sciadv.abe4499 · Cited by 44

Gut-brain axis and Alzheimer's disease: Therapeutic interventions and strategies

Singh, H., Chopra, C., Singh, H., Malgotra, V., Wani, A. K., Dhanjal, D. S., Sharma, I., Nepovimová, E., Alomar, S. Y., Singh, R., et al. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105915 · Cited by 43

Smart conversational agents for the detection of neuropsychiatric disorders: A systematic review

Pacheco-Lorenzo, M. R., Valladares‐Rodríguez, S., Anido, L., & Iglesias, M. J. F. (2020) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2020.103632 · Cited by 44

The Unfolded Protein Response in Immune Cells as an Emerging Regulator of Neuroinflammation

Fernández, D., Geisse, A., Bernales, J. I., Lira, A., & Osorio, F. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.682633 · Cited by 44

Recent Development in the Understanding of Molecular and Cellular Mechanisms Underlying the Etiopathogenesis of Alzheimer’s Disease

Afsar, A., Castro, M. D. C. C., Soladogun, A. S., & Li, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087258 · Cited by 45

A Novel Approach to Delayed-Start Analyses for Demonstrating Disease-Modifying Effects in Alzheimer’s Disease

Liu‐Seifert, H., Andersen, S. W., Lipkovich, I. A., Holdridge, K. C., & Siemers, E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119632 · Cited by 43

Microtubule Affinity Regulating Kinase Activity in Living Neurons Was Examined by a Genetically Encoded Fluorescence Resonance Energy Transfer/Fluorescence Lifetime Imaging-based Biosensor

Timm, T., von Kries, J. P., Li, X., Zempel, H., Mandelkow�, E., & Mandelkow, E.-M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.257865 · Cited by 43

Amyloid‐β oligomers interact with neurexin and diminish neurexin‐mediated excitatory presynaptic organization

Naito, Y., Tanabe, Y., Lee, A. K., Hamel, E., & Takahashi, H. (2017) · Scientific Reports · doi:10.1038/srep42548 · Cited by 42

Metabolomic and lipidomic signatures in autosomal dominant and late‐onset Alzheimer's disease brains

Novotny, B. C., Fernández, M. V., Wang, C., Budde, J., Bergmann, K., Eteleeb, A. M., Bradley, J. L., Webster, C., Ebl, C., Norton, J. B., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12800 · Cited by 42

Multiple Function Fluorescein Probe Performs Metal Chelation, Disaggregation, and Modulation of Aggregated Aβ and Aβ-Cu Complex

Balakrishnan, M., Layek, S., Balaji, S., Trivedi, V., & Iyer, P. K. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00205 · Cited by 42

In vivo Differential Brain Clearance and Catabolism of Monomeric and Oligomeric Alzheimer's Aβ protein

McIntee, F. L., Giannoni, P., Blais, S. P., Sommer, G., Neubert, T. A., Rostagno, A. A., & Ghiso, J. A. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00223 · Cited by 42

Validating GWAS Variants from Microglial Genes Implicated in Alzheimer’s Disease

dos Santos, L. R., Pimassoni, L. H. S., Sena, G. G. S., Camporez, D., Belcavello, L., Trancozo, M., Morelato, R. L., Errera, F. I. V., Passos‐Bueno, M. R., & Paula, F. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0928-7 · Cited by 42

Learning to Detect Cognitive Impairment through Digital Games and Machine Learning Techniques

Pérez‐Rodríguez, R., Iglesias, M. J. F., Anido, L., Facal-Mayo, D., Costa, C. R., & Valladares‐Rodríguez, S. (2018) · Methods of Information in Medicine · doi:10.3414/me17-02-0011 · Cited by 42

Modulating Hinge Flexibility in the APP Transmembrane Domain Alters γ-Secretase Cleavage

Götz, A., Mylonas, N. T., Högel, P., Silber, M., Heinel, H., Menig, S., Vogel, A., Feyrer, H., Huster, D., Luy, B., et al. (2019) · Biophysical Journal · doi:10.1016/j.bpj.2019.04.030 · Cited by 42

Gut microbiota mediated allostasis prevents stress-induced neuroinflammatory risk factors of Alzheimer's disease

Westfall, S., Iqbal, U. H., Sebastian-Valverde, M., & Pasinetti, G. M. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.06.013 · Cited by 42

APOE Antibody Inhibits Aβ‐Associated Tau Seeding and Spreading in a Mouse Model

Gratuze, M., Jiang, H., Wang, C., Xiong, M., Bao, X., & Holtzman, D. M. (2022) · Annals of Neurology · doi:10.1002/ana.26351 · Cited by 41

Dual roles of Aβ in proliferative processes in an amyloidogenic model of Alzheimer’s disease

Baglietto‐Vargas, D., Sánchez‐Mejías, E., Navarro, V., Jiménez, S., Trujillo‐Estrada, L., Gómez-Arboledas, Á., Sanchez-Mico, M. V., Sanchez-Varo, R. M., Vizuete, M., Dávila, J. C., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10353-7 · Cited by 41

Bidirectional relationships between sleep and amyloid-beta in the hippocampus

Dufort‐Gervais, J., Mongrain, V., & Brouillette, J. (2018) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2018.06.009 · Cited by 41

Therapeutic potential of dental pulp stem cell transplantation in a rat model of Alzheimer’s disease

Zhang, X., Ouyang, Y.-J., Yu, B.-Q., Li, W., Yu, M.-Y., Li, J.-Y., Jiao, Z., Yang, D., Li, N., Shi, Y., et al. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.297088 · Cited by 41

Amyloid‐β induces sleep fragmentation that is rescued by fatty acid binding proteins in Drosophila

Gerstner, J. R., Lenz, O., Vanderheyden, W. M., Chan, M. T., Pfeiffenberger, C., & Pack, A. I. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23778 · Cited by 40

Involvement of RhoA/ROCK Signaling in Aβ-Induced Chemotaxis, Cytotoxicity and Inflammatory Response of Microglial BV2 Cells

Zhang, X., Ye, P., Wang, D., Liu, Y., Cao, L., Wang, Y., Xu, Y., & Zhu, C. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00668-6 · Cited by 40

Circular RNA aptamers targeting neuroinflammation ameliorate Alzheimer disease phenotypes in mouse models

Feng, X., Jiang, B., Zhai, S.-N., Liu, C., Wu, H., Zhu, B.-Q., Wei, M.-Y., Wei, J., Yang, L. C., & Chen, L. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02624-w · Cited by 40

Autosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical AD

Schindler, S. E., & Fagan, A. M. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00142 · Cited by 40

Changes in astrocyte functional markers and β-amyloid metabolism-related proteins in the early stages of hypercholesterolemia

Chen, Y. L., Wang, L.-Y., Chen, Y., Gao, J. Y., Marshall, C., Cai, Z., Hu, G., & Xiao, M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.12.039 · Cited by 40

Diagnosis and prognosis of Alzheimer's disease using brain morphometry and white matter connectomes

Wang, Y., Xu, C., Park, J. H., Lee, S., Stern, Y., Yoo, S., Kim, J. H., Kim, H. S., Cha, J., & Initiative, T. A. D. N. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101859 · Cited by 40

The Emerging Roles and Therapeutic Potential of Soluble TREM2 in Alzheimer’s Disease

Zhong, L., & Chen, X. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00328 · Cited by 40

The Role of Natural Killer Cells in Alzheimer’s Disease

Jadidi‐Niaragh, F., Shegarfi, H., Naddafi, F., & Mirshafiey, A. (2012) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2012.02769.x · Cited by 40

Discovery of Novel Inhibitors of Amyloid β-Peptide 1–42 Aggregation

López, L. C., Reis, S. D., Espargaró, A., Carrodeguas, J. A., Maddelein, M., Ventura, S., & Sancho, J. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301186p · Cited by 39

Human fibroblast and stem cell resource from the Dominantly Inherited Alzheimer Network

the Dominantly Inherited Alzheimer Network (DIAN), Karch, C. M. M., Hernández, D., Wang, J., Marsh, J. A., Hewitt, A. W., Hsu, S., Norton, J. B., Levitch, D., Donahue, T. A., et al. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0400-0 · Cited by 39

Attempt to Untangle the Prion-Like Misfolding Mechanism for Neurodegenerative Diseases

Sarnataro, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103081 · Cited by 39

Human Albumin Impairs Amyloid β-peptide Fibrillation Through its C-terminus: From docking Modeling to Protection Against Neurotoxicity in Alzheimer's disease

Picón-Pagès, P., Bonet, J., Garcı́a-Garcı́a, J., Garcia-Buendia, J., Gutiérrez, D. A., Valle, J., Gómez-Casuso, C. E. S., Sidelkivska, V., Alvarez, A. R., Perálvarez‐Marín, A., et al. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.06.017 · Cited by 39

The Latest Research on RT-QuIC Assays—A Literature Review

Dong, T.-T.-T., & Satoh, K. (2021) · Pathogens · doi:10.3390/pathogens10030305 · Cited by 39

Senescent Microglia Represent a Subset of Disease-Associated Microglia in P301S Mice

Ng, P. Y., Zhang, C., Li, H., & Baker, D. J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230109 · Cited by 38

Changes in White Matter Integrity before Conversion from Mild Cognitive Impairment to Alzheimer’s Disease

Defrancesco, M., Egger, K. E., Marksteiner, J., Esterhammer, R., Hinterhuber, H., Deisenhammer, E., & Schocke, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106062 · Cited by 38

Current druggable targets for therapeutic control of Alzheimer's disease

Gupta, G. L., & Samant, N. P. (2021) · Contemporary Clinical Trials · doi:10.1016/j.cct.2021.106549 · Cited by 38

Meta-Analysis of Neurochemical Changes Estimated via Magnetic Resonance Spectroscopy in Mild Cognitive Impairment and Alzheimer's Disease

Liu, H., Zhang, D., Lin, H., Zhang, Q., Zheng, L., Zheng, Y., Yin, X., Li, Z., Liang, S., & Huang, S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.738971 · Cited by 38

Cerebral β-Amyloidosis in Mice Investigated by Ultramicroscopy

Jährling, N., Becker, K., Wegenast‐Braun, B. M., Grathwohl, S. A., Jucker, M., & Dodt, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125418 · Cited by 38

Targeting SUMO-1ylation Contrasts Synaptic Dysfunction in a Mouse Model of Alzheimer’s Disease

Marcelli, S., Ficulle, E., Iannuzzi, F., Kövari, E., Nisticò, R., & Feligioni, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0176-9 · Cited by 38

Penthorum chinense Pursh inhibits ferroptosis in cellular and Caenorhabditis elegans models of Alzheimerʼs disease

Yong, Y.-Y., Yan, L., Wang, B.-D., Fan, D., Guo, M., Yu, L., Wu, J., Qin, D., Law, B. Y. K., Wong, V. K.-W., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155463 · Cited by 37

Use of proteomic methods in the analysis of human body fluids in A lzheimer research

Zürbig, P., & Jahn, H. (2012) · Electrophoresis · doi:10.1002/elps.201200360 · Cited by 37

Differential Expression of Proteins in Brain Regions of Alzheimer’s Disease Patients

Zahid, S., Oellerich, M., Asif, A. R., & Ahmed, N. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1210-1 · Cited by 37

Solvation-Guided Design of Fluorescent Probes for Discrimination of Amyloids

Cao, K., Elbel, K. M., Cifelli, J. L., Cirera, J., Sigurdson, C. J., Paesani, F., Theodorakis, E. A., & Yang, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-25131-2 · Cited by 37

Promoter DNA hypermethylation – Implications for Alzheimer’s disease

Liu, Y., Wang, M., Marcora, E. M., Zhang, B., & Goate, A. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134403 · Cited by 37

Risk Factors for Alzheimer’s Disease: Focus on Stress

Caruso, A., Nicoletti, F., Gaetano, A., & Scaccianoce, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00976 · Cited by 37

Eriodictyol and Homoeriodictyol Improve Memory Impairment in Aβ25–35-Induced Mice by Inhibiting the NLRP3 Inflammasome

Guo, P., Zeng, M., Wang, S., Cao, B., Liu, M., Zhang, Y., Jia, J., Zhang, Q., Zhang, B., Wang, R., et al. (2022) · Molecules · doi:10.3390/molecules27082488 · Cited by 37

Behavioural Phenotyping of APPswe/PS1δE9 Mice: Age-Rrelated Changes and Effect of Long-Term Paroxetine Treatment

Olesen, L. Ø., Bouzinova, E. V., Severino, M., Sivasaravanaparan, M., Hasselstrøm, J. B., Finsen, B. R., & Wiborg, O. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165144 · Cited by 37

Circadian Rhythms in AD Pathogenesis: a Critical Appraisal

Musiek, E. S. (2017) · Current Sleep Medicine Reports · doi:10.1007/s40675-017-0072-5 · Cited by 37

Alzheimer's Disease—Current Status and Future Directions

Bhardwaj, D., Mitra, C., Narasimhulu, C. A., Riad, A., Doomra, M., & Parthasarathy, S. (2017) · Journal of Medicinal Food · doi:10.1089/jmf.2017.0093 · Cited by 37

Cornel Iridoid Glycoside Inhibits Tau Hyperphosphorylation via Regulating Cross-Talk Between GSK-3β and PP2A Signaling

Yang, C., Li, X., Gao, W., Wang, Q., Zhang, L., Li, Y., Li, L., & Zhang, L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00682 · Cited by 36

Genetic Variants of Lipoprotein Lipase and Regulatory Factors Associated with Alzheimer’s Disease Risk

D. Bruce, K., Tang, M., Reigan, P., & H. Eckel, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218338 · Cited by 36

Quantitative Amyloid Imaging Using Image-Derived Arterial Input Function

Su, Y., Blazey, T., Snyder, A. Z., Raichle, M. E., Hornbeck, R. C., Aldea, P., Morris, J. C., & Benzinger, T. L. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122920 · Cited by 36

The 5-Lipoxygenase as modulator of Alzheimer’s γ-secretase and therapeutic target

Chu, J., & Praticò, D. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.03.010 · Cited by 36

Toxicological Differences Between NMDA Receptor Antagonists and Cholinesterase Inhibitors

Shi, X., Lin, X., Hu, R., Sun, N., Hao, J., & Gao, C. (2016) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317515622283 · Cited by 36

KIR2DS2/KIR2DL2/HLA-C1 Haplotype Is Associated with Alzheimer’s Disease: Implication for the Role of Herpesvirus Infections

Rizzo, R., Bortolotti, D., Gentili, V., Rotola, A., Bolzani, S., Caselli, E., Tola, M. R., & Luca, D. D. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180777 · Cited by 36

A Night-Time Monitoring System (eNightLog) to Prevent Elderly Wandering in Hostels: A Three-Month Field Study

Cheung, J. C., Tam, E. W.-C., Mak, A. H.-Y., Chan, T. T.-C., & Zheng, Y. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19042103 · Cited by 36

Rapid Dissolution of Amyloid β Fibrils by Silver Nanoplates

Swathi, S., & Mani, E. (2019) · Langmuir · doi:10.1021/acs.langmuir.9b00080 · Cited by 36

Sex and Sleep Disruption as Contributing Factors in Alzheimer’s Disease

Johnson, C. E., Duncan, M. J., & Murphy, M. P. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230527 · Cited by 34

Roles of zinc ions and structural polymorphism of β-amyloid in the development of Alzheimer’s disease

Kulikova, A. A., Makarov, A. А., & Kozin, S. A. (2015) · Molecular Biology · doi:10.1134/s0026893315020065 · Cited by 35

Olfactory Functions Scale with Circuit Restoration in a Rapidly Reversible Alzheimer's Disease Model

Cheng, N., Bai, L., Steuer, E. R., & Belluscio, L. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0291-13.2013 · Cited by 35

Caffeine, Through Adenosine A3 Receptor-Mediated Actions, Suppresses Amyloid-β Protein Precursor Internalization and Amyloid-β Generation

Li, S., Geiger, N. H., Soliman, M. L., Hui, L., Geiger, J. D., & Chen, X. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142223 · Cited by 35

Preserved Calretinin Interneurons in an App Model of Alzheimer’s Disease Disrupt Hippocampal Inhibition via Upregulated P2Y1 Purinoreceptors

Shi, A., Petrache, A. L., Shi, J., & Ali, A. B. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz165 · Cited by 36

SIRT1-Dependent Upregulation of BDNF in Human Microglia Challenged with Aβ: An Early but Transient Response Rescued by Melatonin

Caruso, G. I., Spampinato, S. F., Costantino, G., Merlo, S., & Sortino, M. A. (2021) · Biomedicines · doi:10.3390/biomedicines9050466 · Cited by 35

Vascular contributions to cognitive impairment and dementia: the emerging role of 20-HETE

Gonzalez‐Fernandez, E., Liu, Y., Auchus, A. P., Fan, F., & Roman, R. J. (2021) · Clinical Science · doi:10.1042/cs20201033 · Cited by 35

Beyond Amyloid

Lane, R. F., Shineman, D. W., Steele, J., Lee, L. H., & Fillit, H. M. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-394816-8.00007-6 · Cited by 35

Involvement of the Bradykinin B1 Receptor in Microglial Activation: In Vitro and In Vivo Studies

Asraf, K., Torika, N., Danon, A., & Fleisher‐Berkovich, S. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00082 · Cited by 35

Carbon dots as dual inhibitors of tau and amyloid-beta aggregation for the treatment of Alzheimer's disease

Zhang, W., Smith, N. S., Zhou, Y., McGee, C. M., Bartoli, M., Fu, S., Chen, J., Domena, J. B., Joji, A., Burr, H., et al. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.06.001 · Cited by 34

Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors

Roldán-Peña, J. M., Romero-Real, V., Hicke, J., Maya, I., Franconetti, A., Lagunes, I., Padrón, J. M., Petralla, S., Poeta, E., Naldi, M., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.07.053 · Cited by 34

A positive allosteric modulator of mGluR5 promotes neuroprotective effects in mouse models of Alzheimer's disease

Bellozi, P. M. Q., Gomes, G. F., da Silva, M. C. M., Lima, I. V. D. A., Batista, C. R. Á., Carneiro, W. D. O., Doria, J. G., Vieira, É. L. M., Vieira, R. P., de Freitas, R. P., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107785 · Cited by 34

Novel presenilin 1 and 2 double knock-out cell line for in vitro validation of PSEN1 and PSEN2 mutations

Pimenova, A. A., & Goate, A. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104785 · Cited by 34

Block copolymers in Alzheimer's disease therapy: A perceptive to revolutionize biomaterials

Revdekar, A., & Shende, P. K. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.007 · Cited by 34

Expression of A2V-mutated Aβ in Caenorhabditis elegans results in oligomer formation and toxicity

Diomede, L., Fede, G. D., Romeo, M., Bagnati, R., Ghidoni, R., Fiordaliso, F., Salio, M., Rossi, A., Catania, M., Paterlini, A., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.10.024 · Cited by 34

Valproic acid attenuates Aβ25-35-induced neurotoxicity in PC12 cells through suppression of mitochondria-mediated apoptotic pathway

Zhao, L., Zhu, L., & Guo, X. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.080 · Cited by 33

Plasma Clusterin as a Potential Link Between Diabetes and Alzheimer Disease

Ha, J.-H., Moon, M. K., Kim, H., Park, M., Cho, S. Y., Lee, J., Lee, J., & Kim, E. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa378 · Cited by 33

Applications of Carbon Dots for the Treatment of Alzheimer’s Disease

Guo, F. W., Li, Q., Zhang, X., Liu, Y., Jiang, J., Cheng, S., Si, Y., Zhang, X., Liu, F., Li, Y., et al. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s388030 · Cited by 33

Original article Paeoniflorin attenuates Aβ 25-35 -induced neurotoxicity in PC12 cells by preventing mitochondrial dysfunction

Li, J., Ji, X., Zhang, J., Shi, G., Xue, Z., & Wang, K. (2014) · Folia Neuropathologica · doi:10.5114/fn.2014.45569 · Cited by 33

Human APOE genotype affects intraneuronal A 1-42 accumulation in a lentiviral gene transfer model

Zhao, W., Dumanis, S. B., Tamboli, I. Y., Rodriguez, G. A., Jo LaDu, M., Moussa, C. E. H., & William Rebeck, G. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt525 · Cited by 32

The Interaction Between Sleep and Metabolism in Alzheimer’s Disease: Cause or Consequence of Disease?

Carroll, C. M., & Macauley, S. L. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00258 · Cited by 32

How the formation of amyloid plaques and neurofibrillary tangles may be related: a mathematical modelling study

Kuznetsov, I. A., & Kuznetsov, A. V. (2018) · Proceedings of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rspa.2017.0777 · Cited by 32

Focus on the Correlations between Alzheimer’s Disease and Type 2 Diabetes

Fiore, V., Rosa, A. D., Falasca, P., Marci, M., Guastamacchia, E., Licchelli, B., Giagulli, V. A., Pergola, G. D., Poggi, A., & Triggiani, V. (2019) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530319666190311141855 · Cited by 32

Roles and Mechanisms of the Protein Quality Control System in Alzheimer’s Disease

Liu, Y., Ding, R., Xu, Z., Xue, Y., Zhang, D., Zhang, Y., Li, W., & Li, X. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010345 · Cited by 32

Impaired Eukaryotic Elongation Factor 1A Expression in Alzheimer's Disease

Beckelman, B. C., Zhou, X., Keene, C. D., & Ma, T. (2015) · Neurodegenerative Diseases · doi:10.1159/000438925 · Cited by 32

Targeting β-Amyloid Plaques and Oligomers: Development of Near-Ir Fluorescence Imaging Probes

Liu, H., Yang, J., Wang, L., Xu, Y., Zhang, S., Lv, J., Ran, C., & Li, Y. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0185 · Cited by 32

Heme Oxygenase-1 Activity as a Correlate to Exercise-Mediated Amelioration of Cognitive Decline and Neuropathological Alterations in an Aging Rat Model of Dementia

Kurucz, A., Bombicz, M., Kiss, R., Priksz, D., Varga, B., Hortobágyi, T., Trencsényi, G., Szabó, R., Pósa, A., Gesztelyi, R., et al. (2018) · BioMed Research International · doi:10.1155/2018/7212861 · Cited by 32

Naturally Inspired Coumarin Derivatives in Alzheimer’s Disease Drug Discovery: Latest Advances and Current Challenges

Orioli, R., Belluti, F., Gobbi, S., Rampa, A., & Bisi, A. (2024) · Molecules · doi:10.3390/molecules29153514 · Cited by 31

Rare Genetic Variants of the Transthyretin Gene Are Associated with Alzheimer’s Disease in Han Chinese

Xiang, Q., Bi, R., Xu, M., Zhang, D., Tan, L., Zhang, C., Fang, Y., & Yao, Y. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0065-2 · Cited by 31

Epidemiology and Risk Factors of Alzheimer’s disease in Iran: A Systematic Review

Navipour, E., Neamatshahi, M., Barabadi, Z., Neamatshahi, M., & Keykhosravi, A. (2020) · Iranian Journal of Public Health · doi:10.18502/ijph.v48i12.3544 · Cited by 31

Sex differences in Alzheimer's disease: do differences in tau explain the verbal memory gap?

Banks, S. J., Andrews, M., Digma, L. A., Madsen, J. R., Reas, E. T., Caldwell, J., McEvoy, L. K., Fan, C. C., Dale, A. M., & Brewer, J. B. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.05.013 · Cited by 31

Dysregulation of sphingosine-1-phosphate (S1P) and S1P receptor 1 signaling in the 5xFAD mouse model of Alzheimer’s disease

Jung, Y., Lopez-Benitez, J., Tognoni, C. M., Carreras, I., & Dedeoglu, A. (2022) · Brain Research · doi:10.1016/j.brainres.2022.148171 · Cited by 31

Systems-Level G Protein-Coupled Receptor Therapy Across a Neurodegenerative Continuum by the GLP-1 Receptor System

Janssens, J., Etienne, H., Idriss, S., Azmi, A., Martin, B., & Maudsley, S. R. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00142 · Cited by 31

Role of LDL Cholesterol and Endolysosomes in Amyloidogenesis and Alzheimer’s Disease

Chen, X. (2014) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.1000236 · Cited by 31

APP Overexpression Causes Aβ-Independent Neuronal Death through Intrinsic Apoptosis Pathway

Cheng, N., Jiao, S., Gumaste, A., Bai, L., & Belluscio, L. (2016) · eNeuro · doi:10.1523/eneuro.0150-16.2016 · Cited by 31

Translational control in brain pathologies: biological significance and therapeutic opportunities

Delaidelli, A., Jan, A., Herms, J. W., & Sorensen, P. H. B. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01971-8 · Cited by 31

Donepezil Derivatives Targeting Amyloid-β Cascade in Alzheimer's Disease

Mezeiová, E., Chalupova, K., Nepovimová, E., Górecki, L., Prchal, L., Maliňák, D., Kuča, K., Soukup, O., & Korábečný, J. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190228122956 · Cited by 31

Reduction of Tet2 exacerbates early stage Alzheimer’s pathology and cognitive impairments in 2×Tg-AD mice

Li, L., Qiu, Y., Miao, M., Liu, Z., Li, W., Zhu, Y., & Wang, Q. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz282 · Cited by 30

Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer’s disease and implicate its dynamic role in disease progression

Wang, Q., Chen, Y., Readhead, B. P., Chen, K., Su, Y., Reiman, E. M., & Dudley, J. T. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00984-5 · Cited by 32

Novel Alzheimer’s disease risk variants identified based on whole-genome sequencing of APOE ε4 carriers

Park, J.-H., Park, I., Youm, E. M., Lee, S., Park, J.-H., Lee, J., Lee, D. Y., Byun, M. S., Lee, J. H., Yi, D., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01412-9 · Cited by 30

Multiomics Identification of Potential Targets for Alzheimer Disease and Antrocin as a Therapeutic Candidate

Wu, A. T. H., Lawal, B., Wei, L., Wen, Y.-T., Tzeng, D. T. W., & Lo, W. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101555 · Cited by 30

Prevalence of sleep-related breathing disorders and associated risk factors among people with dementia: A meta-analysis

Aini, N., Chu, H., Banda, K. J., Chen, R., Lee, T., Pien, L., Liu, D., Lai, Y.-J., Kang, X. L., & Chou, K. (2023) · Sleep Medicine · doi:10.1016/j.sleep.2023.01.020 · Cited by 30

GLP-1 Analogs, SGLT-2, and DPP-4 Inhibitors: A Triad of Hope for Alzheimer’s Disease Therapy

Złotek, M., Kurowska, A., Herbet, M., & Piątkowska‐Chmiel, I. (2023) · Biomedicines · doi:10.3390/biomedicines11113035 · Cited by 30

Association Between Serum Triglycerides and Cerebral Amyloidosis in Cognitively Normal Elderly

Choi, H. J., Byun, M. S., Yi, D., Choe, Y. M., Sohn, B. K., Baek, H., Lee, J. H., Kim, H. J., Han, J., Yoon, E. J., et al. (2016) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.03.001 · Cited by 30

Mapping the Road Forward in Alzheimer’s Disease

Holtzman, D. M., Goate, A., Kelly, J. W., & Sperling, R. A. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003529 · Cited by 81

Progress of translational research on the diagnosis and treatment of Alzheimer's disease and other dementias

Li, B., Xu, W., Deng, Y., Ma, J., Wang, G., Tang, H., Ding, J., Cheng, Q., & Chen, S. (2018) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1

Challenges in Early Diagnosis and Treatment of Alzheimer’s Disease

Jiang, A. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/3knv6p63 · Cited by 4

Alzheimer's disease

Kumar, S., Hasan, M., Singhal, S., & Anupam, A. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns8.10006 · Cited by 2

The molecular basis and genetic determinants of Alzheimer’s disease

Bayer, A. J. (1999) · Reviews in Clinical Gerontology · doi:10.1017/s0959259899009429